Status:
COMPLETED
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
Cirrhosis
Hepatocellular Carcinoma
Eligibility:
All Genders
Brief Summary
Although serum alpha-fetoprotein level and abdominal sonography are the main methods to screening hepatocellular carcinoma (HCC) in cirrhotic patients, the adequate time and methods used are not compl...
Detailed Description
Well-diagnosed consecutive patients with cirrhosis were enrolled through a designed questionnaire to obtain basic information about gender, age, etiology of cirrhosis, conventional liver function test...
Eligibility Criteria
Inclusion
- Image diagnosis or biochemical diagnosis or presence of portal hypertension
Exclusion
- Presence of hepatocellular carcinoma
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00629421
Start Date
January 1 2001
End Date
December 31 2016
Last Update
August 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan, 807